Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gaafar

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)Rabab M Gaafar, Veerle F Surmont, Giorgio V Scagliotti, et al.
American Journal of Medical Genetics. Part A|September 10, 2020
Prenatal delineation of a distinct lethal fetal syndrome caused by a homozygous truncating KIDINS220 variantSara H El-Dessouky, Mahmoud Y Issa, Mona M Aboulghar, et al.
Plants (Basel, Switzerland)|October 27, 2022
Role of Antioxidant Enzymes and Glutathione S-Transferase in Bromoxynil Herbicide Stress Tolerance in Wheat PlantsReda M Gaafar, Mohamed El-Anwar H Osman, Atef M Abo-Shady, et al.
International Journal of Ophthalmology|February 28, 2019
Launching a paradigm for first and redo-surgery in primary congenital glaucoma: institutional experienceTharwat H Mokbel, Eman M El Hefney, Sherein M Hagras, et al.
Experimental and Molecular Pathology|April 17, 2012
Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patientsAbeer A Bahnassy, Abdel-Rahman N Zekri, Amany A Abou-Bakr, et al.
Clinical and Experimental Dental Research|September 30, 2022
Epithelial PD-L1 expression at tumor front predicts overall survival in a cohort of oral squamous cell carcinomas from SudanNuha M Gaafar, Tarig Al-Hadi Osman, Mariam Elsheikh, et al.
Prenatal Diagnosis|August 25, 2020
Raine syndrome: Prenatal diagnosis based on recognizable fetal facial features and characteristic intracranial calcificationSara H El-Dessouky, Mohamed S Abdel-Hamid, Sherif F Abdel-Ghafar, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)Mary E R O'Brien, Rabab M Gaafar, Sanjay Popat, et al.
Journal of Perinatal Medicine|September 9, 2019
Fetal heart examination at the time of 13 weeks scan: a 5 years' prospective studyAlaa Ebrashy, Mona Aboulghar, Mohamed Elhodiby, et al.
The Lancet. Oncology|May 14, 2018
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trialVanesa Gregorc, Rabab M Gaafar, Adolfo Favaretto, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)Rabab M Gaafar, Veerle F Surmont, Giorgio V Scagliotti, et al.
American Journal of Medical Genetics. Part A|September 10, 2020
Prenatal delineation of a distinct lethal fetal syndrome caused by a homozygous truncating KIDINS220 variantSara H El-Dessouky, Mahmoud Y Issa, Mona M Aboulghar, et al.
Plants (Basel, Switzerland)|October 27, 2022
Role of Antioxidant Enzymes and Glutathione S-Transferase in Bromoxynil Herbicide Stress Tolerance in Wheat PlantsReda M Gaafar, Mohamed El-Anwar H Osman, Atef M Abo-Shady, et al.
International Journal of Ophthalmology|February 28, 2019
Launching a paradigm for first and redo-surgery in primary congenital glaucoma: institutional experienceTharwat H Mokbel, Eman M El Hefney, Sherein M Hagras, et al.
Experimental and Molecular Pathology|April 17, 2012
Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patientsAbeer A Bahnassy, Abdel-Rahman N Zekri, Amany A Abou-Bakr, et al.
Clinical and Experimental Dental Research|September 30, 2022
Epithelial PD-L1 expression at tumor front predicts overall survival in a cohort of oral squamous cell carcinomas from SudanNuha M Gaafar, Tarig Al-Hadi Osman, Mariam Elsheikh, et al.
Prenatal Diagnosis|August 25, 2020
Raine syndrome: Prenatal diagnosis based on recognizable fetal facial features and characteristic intracranial calcificationSara H El-Dessouky, Mohamed S Abdel-Hamid, Sherif F Abdel-Ghafar, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)Mary E R O'Brien, Rabab M Gaafar, Sanjay Popat, et al.
Journal of Perinatal Medicine|September 9, 2019
Fetal heart examination at the time of 13 weeks scan: a 5 years' prospective studyAlaa Ebrashy, Mona Aboulghar, Mohamed Elhodiby, et al.
The Lancet. Oncology|May 14, 2018
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trialVanesa Gregorc, Rabab M Gaafar, Adolfo Favaretto, et al.
Pageof 12